Squamous cell carcinoma of the skin

Jump to navigation Jump to search

Template:DiseaseDisorder infobox

WikiDoc Resources for Squamous cell carcinoma of the skin

Articles

Most recent articles on Squamous cell carcinoma of the skin

Most cited articles on Squamous cell carcinoma of the skin

Review articles on Squamous cell carcinoma of the skin

Articles on Squamous cell carcinoma of the skin in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Squamous cell carcinoma of the skin

Images of Squamous cell carcinoma of the skin

Photos of Squamous cell carcinoma of the skin

Podcasts & MP3s on Squamous cell carcinoma of the skin

Videos on Squamous cell carcinoma of the skin

Evidence Based Medicine

Cochrane Collaboration on Squamous cell carcinoma of the skin

Bandolier on Squamous cell carcinoma of the skin

TRIP on Squamous cell carcinoma of the skin

Clinical Trials

Ongoing Trials on Squamous cell carcinoma of the skin at Clinical Trials.gov

Trial results on Squamous cell carcinoma of the skin

Clinical Trials on Squamous cell carcinoma of the skin at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Squamous cell carcinoma of the skin

NICE Guidance on Squamous cell carcinoma of the skin

NHS PRODIGY Guidance

FDA on Squamous cell carcinoma of the skin

CDC on Squamous cell carcinoma of the skin

Books

Books on Squamous cell carcinoma of the skin

News

Squamous cell carcinoma of the skin in the news

Be alerted to news on Squamous cell carcinoma of the skin

News trends on Squamous cell carcinoma of the skin

Commentary

Blogs on Squamous cell carcinoma of the skin

Definitions

Definitions of Squamous cell carcinoma of the skin

Patient Resources / Community

Patient resources on Squamous cell carcinoma of the skin

Discussion groups on Squamous cell carcinoma of the skin

Patient Handouts on Squamous cell carcinoma of the skin

Directions to Hospitals Treating Squamous cell carcinoma of the skin

Risk calculators and risk factors for Squamous cell carcinoma of the skin

Healthcare Provider Resources

Symptoms of Squamous cell carcinoma of the skin

Causes & Risk Factors for Squamous cell carcinoma of the skin

Diagnostic studies for Squamous cell carcinoma of the skin

Treatment of Squamous cell carcinoma of the skin

Continuing Medical Education (CME)

CME Programs on Squamous cell carcinoma of the skin

International

Squamous cell carcinoma of the skin en Espanol

Squamous cell carcinoma of the skin en Francais

Business

Squamous cell carcinoma of the skin in the Marketplace

Patents on Squamous cell carcinoma of the skin

Experimental / Informatics

List of terms related to Squamous cell carcinoma of the skin

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [2] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Overview

In medicine, squamous cell carcinoma is a form of cancer of the carcinoma type that may occur in many different organs, including the skin, mouth, esophagus, prostate, lungs, and cervix. It is a malignant tumor of epithelium that shows squamous cell differentiation. This type of cancer can be seen on the skin, lips, inside the mouth, throat or esophagus. This type of cancer is characterized by red, scaly skin that becomes an open sore.

Epidemiology and Demographics

Squamous cell carcinoma affects more than 200,000 people in the United States alone every year.

Incidence of squamous cell carcinoma varies with age, gender, race, geography, and genetics. The incidence of SCC increases with age and the peak incidence is usually around 66 years old. Males are affected with SCC at a ratio of 2:1 in comparison to females. Caucasians are more likely to be affected, especially those with fair Celtic skin, if chronically exposed to UV radiation. There are also a few rare congenital diseases predispose to cutaneous malignancy. Incidence of SCC has also been found to increase with decreasing latitude (e.g. southern US, Australia). Tumors are more common on the left side in the US and on the right side in England. This is probably due to asymmetric sun exposure during driving. In certain geographic locations, exposure to arsenic in well water or from industrial sources may significantly increase the risk of SCC. [1]

Risk Factors

Smoking is a significant risk factor. Other risk factors include sun exposure, radiation therapy, exposure to carcinogens, chronic skin irritation or inflammation, genetic diseases, and presence of premalignant lesions. Squamous cell cancer can also occur after organ (e.g. heart, kidney) transplantation. Anti-rejection drugs, that ensure the organ is not rejected by the body, can also suppress the immune system. This can be a major factor towards squamous cell skin cancer.

Related conditions

Terminology

A carcinoma can be characterized as either in situ (confined to the original site) or invasive.

Clinical features

Approximately 200,000 cases of cutaneous squamous cell carcinoma occur in the US per year resulting in ~2000 deaths (Miller and Weinstock, 1994). Excessive ultraviolet radiation exposure, immunosuppression, human papilloma virus infection, certain chronic dermatoses, and topical arsenic exposure are all risk factors for developing squamous cell carcinoma (Schwartz and Stoll, 1999). Solid organ transplant recipients commonly develop squamous cell carcinoma in the setting of immunosuppression and in some instances develop several hundred separate primary tumors over the span of a several years (Jensen et al., 1999).

Most squamous cell carcinomas arise on the sun-damaged skin of the head and neck, with fewer lesions arising on the extremities and occasional tumors occurring on the trunk. Early lesions frequently present as a red, scaly spots. Later lesions may form nodules or firm plaques, either of which can ulcerate ( http://tray.dermatology.uiowa.edu). Diagnosis is established by biopsy and histopathological confirmation. Complete excision is curative in the vast majority of cases. Occasionally squamous cell carcinoma will invade along the perineural layer of peripheral nerves and will extend well beyond the clinically apparent mass. Local recurrence is more common in these instances and when present on the head, direct intracranial extension may occur. Metastases to draining lymph nodes occurs in a minority of cases and disseminated disease is the cause of most squamous cell carcinoma-related deaths. Higher rates of metastasis (~15%) are observed with primary lesions of the lips or ears (Rowe et al., 1992). Radiation therapy is helpful in some cases of locally recurrent disease in which complete resection is difficult to achieve and in cases of limited metastatic disease.

Pathology

The development of squamous cell carcinoma is frequently a multistep process. Early lesions tend to be either actinic keratoses, with atypia of the basal keratinocytic layer of the epidermis or squamous cell carcinoma in situ, in which keratinocytic atypia spans the full thickness epidermis.

These precursors are frequently present adjacent to invasive squamous cell carcinomas which invade the dermis as nests, islands, or cords squamous cells with or occasionally as individual cells. Several grading schemes have been developed for squamous cell carcinoma and incorporate the extent of keratinization (a form of differentiation) and nuclear atypia (Broders, 1932). A widely used scheme divides tumors into well, moderately, or poorly differentiated.

Although poorly differentiated tumors tend to behave more aggressively, well-differentiated tumors can also give rise to metastasis and result in death. Several histologic variants of squamous cell carcinoma have been documented, including verrucous, spindle cell and pseudovascular.

Frequently an actinic keratosis or squamous cell carcinoma overlies the invasive component and the two are focally contiguous. Occasionally squamous tumors arise rapidly, have a crater-form morphology and spontaneously regress. These tumors are known as keratoacanthomas. Some craterform squamous lesions do not regress, but continue to invade and grow and represent invasive squamous cell carcinomas.

Signs & Symptoms

  • The lesion caused by SCC is often asymptomatic
  • Ulcer or reddish skin plaque that is slow growing
  • Intermittent bleeding from the tumor, especially on the lip
  • The clinical appearance is highly variable
  • Usually the tumor presents as an ulcerated lesion with hard, raised edges
  • The tumor may be in the form of a hard plaque or a papule, often with an opalescent quality, with telangiectasia
  • The tumor can lie below the level of the surrounding skin, and eventually ulcerates and invades the underlying tissue
  • The tumor commonly presents on sun-exposed areas (e.g. back of the hand, scalp, lip, and superior surface of pinna)
  • On the lip, the tumor forms a small ulcer, which fails to heal and bleeds intermittently
  • Evidence of chronic skin photodamage, such as multiple actinic keratoses (solar keratoses)
  • The tumor grows relatively slowly
  • Unlike basal cell carcinoma (BCC), squamous cell carcinoma (SCC) has a substantial risk of metastasis
  • Risk of metastasis is higher in SCC arising in scars, on the lower lips or mucosa, and occurring in immunosupressed patients. About *one-third of lingual and mucosal tumors metastasize before diagnosis (these are often related to tobacco and alcohol use)

Diagnosis

Diagnosis is via a biopsy. For the skin, look under skin biopsy.

The pathological appearance of a squamous cell cancer varies with the depth of the biopsy. For that reason, a biopsy including the subcutanous tissue and basalar epithelium, to the surface is necessary for correct diagnosis. The performance of a shave biopsy (see skin biopsy) might not acquire enough information for a diagnosis. An excision biopsy is ideal, but not practical in most cases. An incisional or punch biopsy is preferred. A shave biopsy is least ideal, especially if only the superficial portion is acquired.

Physical Examination

Skin

Squamous cell carcinoma of the skin is often caused by long term exposure to the sun. To be diagnosed, a biopsy is done where a sample is taken and examined under a microscope by a Pathologist. If it is found to be cancerous, a surgery is done to remove it.

Squamous cell carcinomas account for about 20% of non-melanoma skin cancers, (with basal cell carcinomas accounting for about 80%), and are clinically more significant because of their ability to metastasize. Squamous cell carcinoma is usually developed in the epithelial layer of the skin and sometimes in various mucous membranes of the body.

Squamous cell carcinoma is the second most common cancer of the skin (after basal cell carcinoma but more common than melanoma). It usually occurs in areas exposed to the sun, and can generally be treated by excision or mohs surgery only.

Sunlight exposure and immunosuppression are risk factors for SCC of the skin with chronic sun exposure being the strongest environmental risk factor.[1] The risk of metastasis is low, but is much higher than basal cell carcinoma.

Squamous cell cancers of the lip and ears have high metastatic and recurrence rate (20 to 50%)[2]. Squamous cell cancers of the skin in individuals on immunotherapy or having lymphoproliferative disorders (leukemias) are much more aggressive, regardless of their location.[3]

Australian scientist Ian Frazer who developed the cervical cancer vaccine, says that animal tests have been effective in preventing squamous cell carcinoma in animals, and there may be a human vaccine against this kind of skin cancer within the decade.[4]

Ear Nose and Throat





Esophagus

Esophageal cancer may be due to either squamous cell carcinoma (ESCC) or adenocarcinoma (EAC). SCCs tend to occur closer to the mouth, while adenocarcinomas occur closer to the stomach. Dysphagia (difficulty swallowing, solids worse than liquids) and odynophagia are common initial symptoms. If the disease is localized, esophagectomy may offer the possibility of a cure. If the disease has spread, chemotherapy and radiotherapy are commonly used.

Penis

When squamous cell carcinoma in situ (Bowen's disease) is found on the penis, it is called erythroplasia of Queyrat[10]. This type of cancer respond very well to an experimental agent called Aldara.

Prostate

When associated with the prostate, squamous cell carcinoma is very aggressive in nature. It is difficult to detect as there is no increase in prostate specific antigen levels seen; meaning that the cancer is often diagnosed at an advanced stage.

Lung

When associated with the lung, it often causes ectopic production of parathyroid hormone-related protein (PTHrP), resulting in hypercalcemia.

Vagina and cervix

Vaginal squamous cell carcinoma spreads slowly and usually stays near the vagina, but may spread to the lungs and liver. This is the most common type of vaginal cancer.

Cervix: Squamous cell carcinoma

<youtube v=zB47nE-i8dQ/>


<youtube v=J3kULzKGzws/>

Experimental treatments

In 2007, Australian biopharmaceutical company Clinuvel Pharmaceuticals Limited began clinical trials with a melanocyte-stimulating hormone called melanotan (known by the International Nonproprietary Name afamelanotide, formerly CUV1647)[11] to provide photoprotection for organ transplant patients against squamous cell carcinoma of the skin and actinic keratosis.[12][13]

While Mohs surgery is frequently utilized and often considered the treatment of choice for squamous cell carcinoma of the skin, physicians have utilized the method for the treatment of squamous cell carcinoma of the mouth, throat, and neck.[14]

Aldara (Imiquimod) has been used with great success for squamous cell carcinoma in situ of the skin and the penis. After treatment, the skin resembles normal skin without the usual scarring and morbidity associated with standard excision. Imiquimod is not FDA approved for any squamous cell carcinoma.

References

  1. 1.0 1.1 Cutaneous squamous cell carcinoma
  2. http://www.aad.org/public/publications/pamphlets/sun_squamous.html
  3. http://www.skincarephysicians.com/skincancernet/squamous_cell_carcinoma.html
  4. Cosmos Online - Skin cancer vaccine within reach (http://www.cosmosmagazine.com/news/2327/skin-cancer-vaccine-within-reach)
  5. http://picasaweb.google.com/mcmumbi/USMLEIIImages
  6. http://picasaweb.google.com/mcmumbi/USMLEIIImages
  7. http://www.ghorayeb.com
  8. http://www.ghorayeb.com
  9. http://www.ghorayeb.com
  10. http://www.emedicine.com/derm/TOPIC144.HTM
  11. "World Health Organisation assigns CUV1647 generic name" (PDF). Clinuvel. 2008. Retrieved 2008-06-17.
  12. Clinuvel » Investors » FAQs
  13. PharmaAsia - Clinuvel’s Drug Begins Global Phase II Skin Cancer Trials
  14. Gross, K.G., et al. Mohs Surgery, Fundamentals and Techniques. 1999, Mosby.

External links


Template:Tumors of bone, cartilage, skin, connective, and soft tissue Template:Respiratory and intrathoracic neoplasia Template:Genital neoplasia Template:Epithelial neoplasms Template:SIB

de:Plattenepithelkarzinom he:קרצינומת תאי קשקש nl:Plaveiselcelcarcinoom


Template:WikiDoc Sources